| 1 |
Iuanow E, Kettler M, Slanetz PJ. Spectrum of disease in the male breast [J]. AJR Am J Roentgenol, 2011, 196(3): W247-W259.
|
| 2 |
Cardoso F, Bartlett J, Slaets L, et al. Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program [J]. Ann Oncol, 2018, 29(2): 405-417.
|
| 3 |
Hassett MJ, Somerfield MR, Baker ER, et al. Management of male breast cancer: ASCO guideline [J]. J Clin Oncol, 2020, 38(16): 1849-1863.
|
| 4 |
Elezaby M, Li G, Bhargavan-Chatfield M, et al. ACR BI-RADS assessment category 4 subdivisions in diagnostic mammography: utilization and outcomes in the national mammography database [J]. Radiology, 2018, 287(2): 416-422.
|
| 5 |
Fentiman IS. Male breast cancer is not congruent with the female disease [J]. Crit Rev Oncol Hematol, 2016: S441787775.
|
| 6 |
Jesinger RA. Breast anatomy for the interventionalist [J]. Tech Vasc Interv Radiol, 2014, 17(1): 3-9.
|
| 7 |
Vinod SK, Pendlebury SC. Carcinoma of the male breast: a review of adjuvant therapy [J]. Australas Radiol, 1999, 43(1): 69-72.
|
| 8 |
Ricci P, Cantisani V, Ballesio L, et al. Benign and malignant breast lesions: efficacy of real time contrast-enhanced ultrasound vs. magnetic resonance imaging [J]. Ultraschall Med, 2007, 28(1): 57-62.
|
| 9 |
康佳, 吴桐, 张蕾, 等. 不同分子分型乳腺癌的多模态超声特征和临床病理对照研究 [J]. 中华超声影像学杂志, 2020, 29(4): 330-336.
|
| 10 |
Adler DD, Carson PL, Rubin JM, et al. Doppler ultrasound color flow imaging in the study of breast cancer: Preliminary findings [J]. Ultrasound Med Biol, 1990, 16(6): 553-559.
|
| 11 |
张剑, 陈卉, 徐斌, 等. 超微血管成像、高级动态血流显像、彩色多普勒血流显像对乳腺微小癌的诊断价值及其与病理肿瘤微血管密度的相关性研究 [J]. 中华超声影像学杂志, 2019, 28(9): 787-793.
|
| 12 |
Tang L, Chen Y, Du Z, et al. A multicenter study of a contrast-enhanced ultrasound diagnostic classification of breast lesions [J]. Cancer Manag Res, 2019, 11: 2163-2170.
|
| 13 |
Luo J, Chen J, Chen Q, et al. Predictive model for contrast-enhanced ultrasound of the breast: Is it feasible in malignant risk assessment of breast imaging reporting and data system 4 lesions? [J]. World J Radiol, 2016, 8(6): 600-609.
|
| 14 |
王琳琳, 方建强, 李尔清. 超声造影在乳腺叶状肿瘤与纤维腺瘤鉴别诊断中的价值[J/OL]. 中华医学超声杂志(电子版), 2020, 17(1): 29-32.
|
| 15 |
Pellini F, Granuzzo E, Urbani S, et al. Male breast cancer: surgical and genetic features and a multidisciplinary management strategy [J]. Breast Care(Basel), 2020, 15(1): 14-21.
|
| 16 |
Morakkabati-Spitz N, Schild HH, Leutner CC, et al. Dynamic contrast-enhanced breast MR imaging in men: preliminary results [J]. Radiology, 2006, 238(2): 438-445.
|
| 17 |
Muñoz Carrasco R, Álvarez Benito M, Muñoz Gomariz E, et al. Mammography and ultrasound in the evaluation of male breast disease [J]. Eur Radiol, 2010, 20(12): 2797-2805.
|
| 18 |
施惠芬, 马艳, 顾俊毅, 等. BI-RADS分级在男性乳房疾病超声检查中的应用 [J]. 医学影像学杂志, 2013, 23(3): 412-415.
|
| 19 |
赵佳琦, 何金, 章建全. 男性乳腺癌多模式超声影像学特征分析 [J]. 第二军医大学学报, 2009, 30(8): 917-920.
|
| 20 |
Nowak A, Grzegrzolka J, Paprocka M, et al. Nestin-positive microvessel density is an independent prognostic factor in breast cancer [J]. Int J Oncol, 2017, 51(2): 668-676.
|
| 21 |
Lehotska V, Rauova K, Vanovcanova L. Pitfalls of Contrast Enhanced Ultrasound (CEUS) in determination of breast tumor biological dignity [J]. Neoplasma, 2018, 65(1): 124-131.
|
| 22 |
Nowak A, Grzegrzolka J, Paprocka M, et al. Nestin-positive microvessel density is an independent prognostic factor in breast cancer [J]. Int J Oncol, 2017, 51(2): 668-676.
|
| 23 |
Liu H, Jiang Y, Dai Q, et al. Differentiation of benign and malignant sub-1-cm breast lesions using contrast-enhanced sonography [J]. J Ultrasound Med, 2015, 34(1): 117-123.
|
| 24 |
Liu H, Jiang Y, Dai Q, et al. Peripheral enhancement of breast cancers on contrast-enhanced ultrasound: correlation with microvessel density and vascular endothelial growth factor expression [J]. Ultrasound Med Biol, 2014, 40(2): 293-299.
|
| 25 |
Zhao LX, Liu H, Wei Q, et al. Contrast-enhanced ultrasonography features of breast malignancies with different sizes: correlation with prognostic factors [J]. Biomed Res Int, 2015, 2015: 613831.
|